| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |